ADIPOQ and obesity disorder: Indeed, reductions in circulating adiponectin have been consistently associated with obesity, insulin resistance, type 2 DM, and coronary artery disease [23, 24], whereas recent data have revealed that adiponectin plays a vascular protective role by preserving endothelial cell function in diabetic patients [25].